HLS Therapeutics (HLS Therapeutics Stock Quote, Chart, News TSX:HLS) received a target raise from Stifel GMP analyst Justin Keywood on Thursday as a … [Read more...] about HLS Therapeutics has upside left, says Stifel GMP
Content brought to you by:
The Cantech Letter Life Sciences section is brought to you by Relay Medical Corp. (CSNX:RELA). Relay is in the business of commercializing innovative technologies, protected by issued and pending patents, in the medical diagnostics and research field with an emphasis on In Vitro Diagnostics (IVD) and Point of Care Testing (POCT). Click on the logo for more info...
It was another up and down year for Canadian Life Sciences stocks. In 2018, the downfall of the sector came in the last couple of months. A year … [Read more...] about The Ten Best Performing Canadian Life Sciences Stocks of 2019
Disappointing results for its lead product candidate CaPre have led Mackie research capital analyst André Uddin to place Acasti Pharma (Acasti Pharma … [Read more...] about Acasti Pharma placed under review by Mackie Research Capital
Paradigm Capital analyst Scott McAuley is expecting big things from clinical stage company Zymeworks (Zymeworks Stock Quote, Chart, news NYSE:ZYME) in … [Read more...] about Zymeworks gets huge price target hike at Paradigm Capital
Quebec-based omega-3 drug developer Acasti Pharma (Acasti Pharma Stock Quote, Chart, News TSXV:ACST) is keeping its "Top Pick" status from Echelon … [Read more...] about Acasti Pharma keeps “Top Pick” Status at Echelon for 2020
Based on its strong growth profile for both sales and EBITDA, Stifel Canada analyst Justin Keywood on Tuesday raised his target price for HLS … [Read more...] about HLS Therapeutics gets a price target hike at Stifel Canada
There’s good value to be had in 2020 from biotech stocks, says Eden Rahim of Next Edge Capital, who thinks that, in particular, Montreal-based … [Read more...] about Biotech stocks are ready to roar, this fund manager says
On the back of a US FDA label expansion for Vascepa, Canadian specialty pharma company HLS Therapeutics (HLS Therapeutics Stock Quote, Chart, News … [Read more...] about HLS Therapeutics has a winner in Vascepa, Stifel says
Medical device company Profound Medical (Profound Medical Stock Quote, Chart, News TSX:PRN) is already up 22 per cent over the last two weeks but … [Read more...] about Profound Medical will have a transformative 2020, says Raymond James
Specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) saw its share price spike in October on news of a … [Read more...] about Is Knight Therapeutics worth owning?